RP Cure Tracker

Trials / NCT05793515

Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models

Completed Observational Natural history / observational

Sponsor
Istituto Superiore di Sanità
Treatment
whole genome sequencing
Gene
Not stated
Conditions
Inherited Retinal Dystrophy, Retinitis Pigmentosa, Macular Dystrophy
Ages
5 Years to 80 Years
Enrollment
120 participants
Started
2022-11-15
Main results expected
2024-11-02
Results posted
Not yet
Record last updated
2025-04-18

What the study is testing

Inherited retinal dystrophies (IRDs), a large group of heterogeneous and rare disorders, may result in irreversible bilateral visual loss and blindness. Characterizing the genetic bases of IRDs will help to understand the pathogenesis underlying the development of retinal damage. Despite the advances in molecular identification of genes causing disease, unsolved IRDs constitute about 40% of all cases.

Goal of this study is to solve missing heritability in IRD using whole genome sequencing (WGS) to identify the genetic causes in clinically well-characterized patients without a molecular diagnosis.

The identification of novel genes that have a role in the development or maintenance of retinal function will lead to the development of new therapeutic approaches and will favour a more prompt diagnosis and improvement of patient management.

Where it runs

Italy (1)

Open on ClinicalTrials.gov for contacts and eligibility